Roche has unveiled results from its comprehensive TSIX Study Program evaluating a new high-sensitivity cardiac troponin T assay designed to improve acute myocardial infarction diagnosis in emergency settings. The sixth-generation test, recently granted CE Mark approval, demonstrates significant advances in sensitivity and accuracy for detecting cardiac events.
Takara Bio Europe has introduced Cellartis® MSC EV Wonder™, a chemically defined, xeno-free culture medium designed to address scalability challenges in mesenchymal stem cell-derived extracellular vesicle (MSC-EV) manufacturing. The product targets researchers developing cell-free therapeutic candidates for regenerative medicine and immunomodulation applications.
SynGenSys has introduced NK.SET™, the first commercially available synthetic promoter library designed specifically for natural killer (NK) cell immunotherapies. The Sheffield-based biotechnology company’s announce-ment marks a significant validation of its platform for engineering tissue-specific gene regulation control elements.
Bio-Rad launches consolidated specialty immunoassay quality control in Europe Bio-Rad Laboratories has introduced its Specialty Immunoassay Plus (SPIA Plus) control system to European clinical laboratories, offering enhanced quality monitoring capabilities for specialty immunoassay testing procedures.
Amsbio has launched an expanded portfolio of ready-to-use, sterile cell lines designed to accelerate CAR-T cell therapy research for leukaemia treatment. The offering addresses growing demand for standardised cellular tools following the 2017 FDA approval of CAR-T therapy for children and adolescents with B cell acute lymphoblastic leukaemia (ALL).
Thermo Fisher Scientific has introduced Invitrogen UltraComp eBeads Spectral Unmixing Beads, a next-generation com-pensation tool designed to improve signal accuracy in spectral and conventional flow cytometry applications. The product addresses persistent challenges in fluoro-chrome separation and background inter-ference that can compromise data quality in multi-parameter cellular analysis.
INTEGRA Biosciences has introduced the SWITCH hybrid pipette, a laboratory instrument scientifically evaluated for ergonomics through collaboration with the Zurich University of Applied Sciences (ZHAW). The device combines manual pipetting control with electronic repeat dispense functionality, addressing workplace injury risks associated with repetitive laboratory tasks.
Revvity has introduced Living Image Synergy AI, a unified software platform designed to streamline preclinical imaging analysis across multiple modalities. The solution integrates artificial intelligence capabilities to enhance data analysis for in vivo imaging researchers working with optical, microCT, ultrasound, and other imaging technologies.
Siemens Healthineers has introduced the Atellica DT 250 Analyzer, a benchtop drug testing system designed to deliver clinical-quality results across diverse testing environments, from forensic laboratories to hospital settings.
Cambridge-based Abselion has introduced a Protein G Total Antibody Quantification Kit for its Amperia benchtop platform, extending the system’s analytical capabilities beyond existing Protein A-based formats. The kit enables researchers to quantify antibodies across a broader spectrum of IgG subclasses and species, addressing measurement gaps in humanised antibodies, rodent IgGs, and engineered variants.
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.